Replies to post #6334 on Marketgems Earnings Trader- Trading Strong or Weak (MKTGEMS)

[jenna]

TEVA..will be making an earnings guidance announcement soon and its been showing great stability since the May rally. Still the best of the drug manufacturers especially the likes of MRK and LLY. Be cautious though in the next week or so. Still haven't found a good entry for TARO.

..., Teva said on Wednesday that the US Food and Drug Administration had approved the company's application to market Tizanidine HCl tablets for the treatment of muscle spasticity. Tizanidine is the generic version of Elan Pharmaceuticals Zanaflex, which had annual sales of $178 million. On Monday, Teva reported receipt of FDA final approval to market two hypertension drugs with branded sales of over $1.6 billion a year. Merrill Lynch said on Tuesday that it expected the drugs to add $0.08 - $0.10 to Teva’s bottom line annually.

[Joe Stocks]

TYC- Jenna, The way I see it it appears that TYC will ahve to write off another $2bil or so for the poor reception on the CIT IPO. That and that they still have a tremendous amount of goodwill on the books and I think we may see some more surprises. I have gotten to a point where I don't trust anything this comapny says and every line must be read between. Looks like they just paid too much for some of these companies and I think the stock prices are show it. With as much press this company has received I bet big money has looked it over well. If there was much there they should have responded better to the IPO since that was what was suppose to be their big hang-up.

JMO, Joe